AlzoSure® a simple blood test that predicts clinical Dementia/Alzheimer’s before Cognitive Impairment (>6 years before diagnosis): implications on the diagnostic pathway and treatment with disease-modifying agents for patients – Diadem sponsored symposium

9:05AM to 10:05AM GMT
5:05PM to 6:05PM GMT +8 (Asia/Singapore)
8:05PM to 9:05PM GMT + 11 (Australia/Sydney)
10:05AM to 11:05AM CET (Central European Time)
4:05AM to 5:05AM EST (Eastern Standard Time)

ID:

The panel will discuss the scientific background of the new biomarker, the test performance, initial clinical validation and how it could fit and impact the clinical pathway for Alzheimer’s to try and determine this new and unique tests suitability and potential to improve patients treatment and long term outcomes.

Speakers:

Gerry Móller
Paul Kinnon

Simona Picirrella

Antonio Boniolo

Francesco Granata

Diana Saraceni

Robert Dean

Anne Fagan

Tamas Bartfai

Jeffrey Cummings

weight no A Tagvape no A Tagcbd no A Tagmale no A Tag